Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19

Moderate hypofractionation for prostate cancer

At the end of the last century, Brenner and Hall [1] argued that the fractionation sensitivity of prostate cancer was different from most tumors and normal tissues, with the opportunity to increase the therapeutic ratio by treating this cancer with hypofractionation (fewer, larger daily fractions). Nearly two decades later, the use of moderate hypofractionation for prostate cancer has become an...

SBRT and extreme hypofractionation: A new era in prostate cancer treatments?

AIM Radiation therapy (RT) is a standard therapeutic option for prostate cancer (PC). In the last decades, several innovative technology applications have been introduced. 3-Dimensional conformal RT, volumetric/rotational intensity modulated RT associated or not with image-guided RT, are becoming largely diffused in the treatment of PC. BACKGROUND Considering that PC could have a low α/β rati...

Assessing the Risk of COVID-19 in Workplace Environments using Rapid Risk Analysis

This article has no abstract.

Hypofractionation trials and radiobiology of prostate cancer

The Role of Health Centers Services for Response to COVID-19 in Iran

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus. Iran is one of the countries affected by the disease. Health center services have a critical role in response to the COVID-19 outbreak. This study with the aim of providing the functions and services of primary health care was performed by a health center in Iran during the COVID-19 outb...